Immagina announces a new edition of the Ribo-Omics Grant Challenge in 2025, supporting cutting edge research projects to study ribosome function, translatome, proteomics and tRNA.
From the 3rd to the 7th of September Immagina is attending Cold Spring Harbor Translational Control in New York! Join us there, and have a look at our poster depicting all our translatome solutions
Join us from January 23-25 at the mRNA-Based Therapeutics Summit Europe 2024 - in Berlin - for an introduction by our founder, unraveling the immense potential of leveraging a commercially validated "ribosome platform".